ConductScience.org, home

Paper24928124

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Ryman DC and 25 others. Neurology, 2014. Cited by 425 papers, by iCite.

Cite this record

ConductScience Library. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Papers, record 24928124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24928124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.
PubMed
Journal
Neurology
PubMed
Year
2014
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Systematic Review
PubMed
Citations, by iCite
425
iCite
Relative citation ratio, by iCite
13.7
iCite
Revised in PubMed
2026-02-13
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ryman DCDavis C
2Acosta-Baena NNatalia
3Aisen PSPaul S
4Bird TThomas
5Danek AAdrian
6Fox NCNick C
7Goate AAlison
8Frommelt PPeter
9Ghetti BBernardino
10Langbaum JBJessica B S
11Lopera FFrancisco
12Martins RRalph
13Masters CLColin L
14Mayeux RPRichard P
15McDade EEric
16Moreno SSonia
17Reiman EMEric M
18Ringman JMJohn M
19Salloway SSteve
20Schofield PRPeter R

Source PubMed

See all 26 authorsDownload CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Age of OnsetMajor topic
Alzheimer DiseaseMajor topic
Chromosome DisordersMajor topic
Genes, DominantMajor topic
Humans

Grants16

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 GM046255NIGMS NIH HHSUnited StatesR01GM046255PubMed and NIHNIH RePORTER
GM 46255NIGMS NIH HHSUnited StatesR01GM046255PubMed and NIHNIH RePORTER
P50 AG005136NIA NIH HHSUnited StatesP50AG005136PubMed and NIHNIH RePORTER
R37 AG011762NIA NIH HHSUnited StatesR01AG011762PubMed and NIHNIH RePORTER
P50 AG005134NIA NIH HHSUnited StatesP50AG005134PubMed and NIHNIH RePORTER
R01 AG021544NIA NIH HHSUnited StatesR01AG021544PubMed and NIHNIH RePORTER
R37 GM046255NIGMS NIH HHSUnited StatesR01GM046255PubMed and NIHNIH RePORTER
AG 05136NIA NIH HHSUnited StatesP50AG005136PubMed and NIHNIH RePORTER
P30 AG062421NIA NIH HHSUnited StatesP30AG062421PubMedNIH RePORTER
U19 AG010483NIA NIH HHSUnited StatesU19AG010483PubMed and NIHNIH RePORTER
AG 21544NIA NIH HHSUnited StatesR01AG021544PubMed and NIHNIH RePORTER
R01 AG011762NIA NIH HHSUnited StatesR01AG011762PubMed and NIHNIH RePORTER
AG 11762NIA NIH HHSUnited StatesR01AG011762PubMed and NIHNIH RePORTER
U19 AG032438NIA NIH HHSUnited StatesU19AG032438PubMed and NIHNIH RePORTER
R37AG011762NIHNIH RePORTER
R37GM046255NIHNIH RePORTER

Download CSV of grants

Trials6

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01760005
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
BackgroundClinicalTrials.gov
NCT04623242
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
BackgroundClinicalTrials.gov
NCT05552157A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationBackgroundClinicalTrials.gov
NCT06384573DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseBackgroundClinicalTrials.gov
NCT06424236
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
BackgroundClinicalTrials.gov
NCT06647498A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationBackgroundClinicalTrials.gov

Download CSV of trials

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19343467Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.JAMA1997https://conductscience.org/library/papers/9343467PubMed
216267640Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.J Neurol2006https://conductscience.org/library/papers/16267640PubMed
316327343Survival among patients with dementia from a large multi-ethnic population.Alzheimer Dis Assoc Disord2005https://conductscience.org/library/papers/16327343PubMed
411395394Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.Am J Pathol2001https://conductscience.org/library/papers/11395394PubMed
521971471Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.J Alzheimers Dis2011https://conductscience.org/library/papers/21971471PubMed
69052708Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.JAMA1997https://conductscience.org/library/papers/9052708PubMed
717192785Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.Nat Genet2007https://conductscience.org/library/papers/17192785PubMed
818667258Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.Neurobiol Aging2010https://conductscience.org/library/papers/18667258PubMed
922997326Preventing Alzheimer's disease.Science2012https://conductscience.org/library/papers/22997326PubMed
1015389756APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation.Am J Med Genet B Neuropsychiatr Genet2005https://conductscience.org/library/papers/15389756PubMed
117023604The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease.Brain1981https://conductscience.org/library/papers/7023604PubMed
1212891668Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.Ann Neurol2003https://conductscience.org/library/papers/12891668PubMed
1320375137Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.Brain2010https://conductscience.org/library/papers/20375137PubMed
1421211070Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.Alzheimers Res Ther2011https://conductscience.org/library/papers/21211070PubMed
1524131566Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.Alzheimers Res Ther2013https://conductscience.org/library/papers/24131566PubMed
162025423Familial Alzheimer disease: a large, multigeneration German kindred.Alzheimer Dis Assoc Disord1991https://conductscience.org/library/papers/2025423PubMed
1719604328What is 'early onset dementia'?Psychogeriatrics2009https://conductscience.org/library/papers/19604328PubMed
1814560058A method for estimating duration of illness in Alzheimer's disease.Dement Geriatr Cogn Disord2004https://conductscience.org/library/papers/14560058PubMed
193345066Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect.Ann Neurol1988https://conductscience.org/library/papers/3345066PubMed
2023246540A presenilin 1 mutation in the first case of Alzheimer's disease.Lancet Neurol2013https://conductscience.org/library/papers/23246540PubMed

See all 26 referencesDownload CSV of references

Cited by338

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 425 citations.

PMIDTitleJournalYearIn PapersSource
42877385The single cell origin of sporadic Alzheimer's disease: A developmental biallelic somatic mutation model.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877385PubMed
42856312Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease.medRxiv2026https://conductscience.org/library/papers/42856312PubMed
42853147Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.J Hum Immun2026https://conductscience.org/library/papers/42853147PubMed
42781715Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease.Alzheimers Dement2026https://conductscience.org/library/papers/42781715PubMed
42740027Electrodermal Activity as a Potential Diagnostic Biomarker for Alzheimer's Disease: A Pilot Study.Sensors (Basel)2026https://conductscience.org/library/papers/42740027PubMed
42719037Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies.Alzheimers Dement (N Y)2026https://conductscience.org/library/papers/42719037PubMed
42637536Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.J Neurol Neurosurg Psychiatry2026https://conductscience.org/library/papers/42637536PubMed
42597443Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments.NPJ Dement2026https://conductscience.org/library/papers/42597443PubMed
42569826APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.Alzheimers Dement2026https://conductscience.org/library/papers/42569826PubMed
42395104Novel PSEN1 (Q223 L) mutation causes early-onset Alzheimer's disease: A case report.World J Radiol2026https://conductscience.org/library/papers/42395104PubMed
42204862Recommendations for genetic counseling for individuals at risk of autosomal dominant Alzheimer's disease in Latin America.Alzheimers Dement2026https://conductscience.org/library/papers/42204862PubMed
42022292Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer's disease.Brain Commun2026https://conductscience.org/library/papers/42022292PubMed
42020929Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42020929PubMed
41964075Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment.Alzheimers Res Ther2026https://conductscience.org/library/papers/41964075PubMed
41959774Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.medRxiv2026https://conductscience.org/library/papers/41959774PubMed
41959760Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.medRxiv2026https://conductscience.org/library/papers/41959760PubMed
41913983Screening and functional validations of APP , PSEN1 , and PSEN2 mutations from PUMCH dementia cohort.Chin Med J (Engl)2026https://conductscience.org/library/papers/41913983PubMed
41851792Clinical, neuroimaging, and biomarker profiling of four Alzheimer's disease pedigrees caused by pathogenic APP variants.Alzheimers Res Ther2026https://conductscience.org/library/papers/41851792PubMed
41757216Plasma Proteomic Analysis of APOE ε4 Homozygotes Identifies Preclinical Alzheimer's Disease Alterations Potentially Treatable with Semaglutide.medRxiv2026https://conductscience.org/library/papers/41757216PubMed
41748785Magnetic resonance microscopy maps widespread effects of Alzheimer's disease on brain structures and behavior in mice.Nat Neurosci2026https://conductscience.org/library/papers/41748785PubMed

See all 338 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
PSEN15663PubTator's text mininghttps://conductscience.org/library/genes/5663NCBI Gene
PSEN25664PubTator's text mininghttps://conductscience.org/library/genes/5664NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24928124

GET https://conductscience.org/api/papers/v1/24928124/authors?page=2